Dr. Fabienne Laraque is an internal medicine physician with a preventive medicine/public health specialty and a master in public health, and she is a graduate of the CDC Epidemic Intelligence Service (EIS). From 1997 to 2011, Dr. Laraque worked at the NYC Department of Health and Mental Hygiene (DOHMH), in leadership and research positions in maternal and infant health,
tuberculosis surveillance, and HIV Care, Treatment and Housing. In her various positions, Dr. Laraque conducted breaking ground research and developed and implemented innovative public health programs, such as the landmark Ryan White funded HIV comprehensive care coordination program, serving thousands of patients. As a result of the 2010 earthquake in Haiti, Dr. Laraque decided to join the CDC to implement a field epidemiology training program for the Haitian Ministry of Health, as part of the Haiti Health System Reconstruction Program. She took her family to Haiti from 2011 to 2012. Upon returning to NYC at DOHMH, Dr. Laraque started working on viral hepatitis, and is now the Medical Director of the newly created Viral Hepatitis Surveillance, Prevention and Control. In addition, Dr. Laraque oversees health care provider communications during public health emergencies.
At the completion of this educational session, learners will:
- Understand the epidemiology of and risk factors for HCV infection.
- Be aware of screening recommendations.
- Appreciate the role of primary care and/or HIV providers in improving HCV control.
This CME activity was approved for AMA PRA Category 1 Credit™
on August 19, 2014 and will terminate August, 2017.
The target audience is all physicians, NPs and PAs involved or interested in HIV education.
This online video and post-activity evaluation are one hour in length.
After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz.
You must achieve at least 70% correct to receive your CME certificate.
If successful, you will be provided instructions to print your CME certificate at the completion of this activity.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.
The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™
. Physicians should claim only the credit commensurate with extent of their participation in the activity.
Policies and standards of MSSNY require that speakers and planners for CME activities disclose any relevant financial relationships they may have with commercial interests whose products, devices or services may be discussed in the content of a CME activity.
Dr. James Braun (Planner/Course Director) had no relevant financial relationships to disclose.
Dr. Laraque (Presenter) had no relevant financial relationships to disclose. Dr. Laraque supported her presentation and clinical recommendations with the best available evidence from the medical literature, and submitted her slides in advance for adequate peer review.
This PRN CME activity is funded in part by unrestricted educational grants from:
Bristol-Myers Squibb, Gilead Sciences, Janssen Pharmaceuticals, Merck & Co, and ViiV Healthcare.
To obtain CME credit for this PRN program, please visit the the PRN Courses page
at the Clinical Education Initiative (CEI) web site. PRN and the Medical Society of the State of New York (MSSNY) jointly sponsor PRN enduring materials for CME, and provide them at no cost to the AIDS Institute of the New York State Department of Health (NYSDOH) for broadcast through the CEI. We thank the NYSDOH for making our CME programs available to a wider audience, and hope you will also browse the many other educational opportunities offered by the CEI.